Skip to content
10-Q

Quarterly Report

LAVA MEDTECH ACQUISITION CORP.

0001213900-22-072160

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 $291.71K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $1.13M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $1.54M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$3.5M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$3.6M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$5.35M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$6.47M
Stockholders Equity Q3 2022 · Sep 30, 2021 $18.85K
Stockholders Equity Q3 2022 · Jun 30, 2021 $24K
Current Liabilities Q3 2022 · Sep 30, 2022 $513.55K
Current Liabilities Q3 2022 · Dec 31, 2021 $130.23K
Total Liabilities Q3 2022 · Sep 30, 2022 $5.36M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.9M
Current Assets Q3 2022 · Sep 30, 2022 $1.51M
Current Assets Q3 2022 · Dec 31, 2021 $2.2M
Total Assets Q3 2022 · Sep 30, 2022 $120.09M
Total Assets Q3 2022 · Dec 31, 2021 $120.3M
Sga Expense Q3 2022 · Sep 30, 2022 $326.44K
Sga Expense Q3 2022 · Sep 30, 2022 $1.03M
Sga Expense Q3 2022 · Sep 30, 2021 $5.15K
Sga Expense Q3 2022 · Sep 30, 2021 $6.15K
Net Income Q3 2022 · Sep 30, 2022 $461.37K
Net Income Q3 2022 · Sep 30, 2022 $3.33M
Net Income Q3 2022 · Jun 30, 2022 $1.75M
Net Income Q3 2022 · Mar 31, 2022 $1.12M
Net Income Q3 2022 · Sep 30, 2021 −$5.15K
Net Income Q3 2022 · Sep 30, 2021 −$6.15K
Net Income Q3 2022 · Jun 30, 2021 −$1K